Hudson Bay Capital Management
RPRX icon

Hudson Bay Capital Management’s Royalty Pharma RPRX Stock Holding History

Hudson Bay Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Buy
+44,590
New +$2.32M 0.01% 763
2025
Q4 		– Sell
-29,384
Closed -$1.04M – 1480
2025
Q3 		$1.04M Buy
29,384
+289
+1% +$10.5K ﹤0.01% 858
2025
Q2 		$1.05M Buy
+29,095
New +$964K ﹤0.01% 953
2024
Q1 		– Sell
-160,000
Closed -$4.49M – 862
2023
Q4 		$4.49M Buy
+160,000
New +$4.4M 0.03% 318

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hudson Bay Capital Management's RPRX Position: Q2 2026 in Review

Hudson Bay Capital Management opened a new position in Royalty Pharma (RPRX) in Q2 2026: 44,590 shares worth $2.5M. The stake represents 0.01% of the portfolio and ranks #763 among its holdings. This is a return to the name: Hudson Bay Capital Management previously reported a position in RPRX as recently as Q3 2025.

Hudson Bay Capital Management first reported a position in RPRX in Q4 2023 and has held it in 4 quarters since. The position peaked at $4.49M in Q4 2023. 647 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Hudson Bay Capital Management held 44,590 shares of Royalty Pharma worth $2.5M as of Q2 2026.
  • Royalty Pharma was a new Hudson Bay Capital Management position in Q2 2026.
  • Royalty Pharma made up 0.01% of Hudson Bay Capital Management's portfolio in Q2 2026, its #763 holding.
  • Hudson Bay Capital Management first reported a position in Royalty Pharma in Q4 2023 and has held it in 4 quarters since.
  • Hudson Bay Capital Management's Royalty Pharma position peaked at $4.49M in Q4 2023.
  • 647 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.